Clinical trials
Glaucoma, Open-Angle trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
110 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2006 | 6 |
| 2008 | 4 |
| 2009 | 4 |
| 2010 | 3 |
| 2011 | 4 |
| 2012 | 1 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 6 |
| 2016 | 4 |
| 2017 | 6 |
| 2018 | 3 |
| 2019 | 5 |
| 2020 | 17 |
| 2021 | 9 |
| 2022 | 10 |
| 2023 | 11 |
| 2024 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 110 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Zhongshan Ophthalmic Center, Sun Yat-sen University | 7 |
| Glaukos Corporation | 6 |
| Cairo University | 4 |
| Chong Kun Dang Pharmaceutical | 3 |
| Universitaire Ziekenhuizen KU Leuven | 3 |
| Aurolab | 2 |
| Guy's and St Thomas' NHS Foundation Trust | 2 |
| Kantonsspital Aarau | 2 |
| Military Institute od Medicine National Research Institute | 2 |
| National Eye Institute (NEI) | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glaucoma, Open-Angle | 110 |
| Glaucoma | 33 |
| Ocular Hypertension | 29 |
| Exfoliation Syndrome | 5 |
| Glaucoma, Angle-Closure | 5 |
| Low Tension Glaucoma | 5 |
| Cataract | 4 |
| Eye Diseases | 3 |
| Choroidal Effusions | 1 |
| Corneal Diseases | 1 |
Trials
Showing 1 to 25 of 110. Each trial links to its page on Pharma Observatory.
10 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.